Navigation Links
Tuberculosis Immunotherapy Grant for Immunoxel Honibe Honey Lozenges
Date:2/3/2013

Kiev, Ukraine (PRWEB) February 02, 2013

Ekomed company is pleased to announce that Immunoxel formulated into Honey Lozenges™ has been awarded Global Science & Technology Entrepreneurship Program (STEP) grant from the Civilian Research & Development Foundation (CRDF). CRDF is the non-profit organization authorized by the US Congress and established in 1995 by the National Science Foundation. STEP is funded by the US Department of State and in part by the State Agency of Ukraine for Science, Innovation, and Information. The grant will support clinical trial and joint marketing initiative of honey-formulated herbal supplement, Immunoxel, shown clinically effective as an immune adjunct against tuberculosis.

TB is a global killer. According to the WHO two billion people or 1/3 of the global population is latently infected with Mycobacterium tuberculosis. Annually, nearly 9 million of these people develop active TB and 2 million die. Current tuberculosis drugs are 50 years old, not very effective, must be taken for 6-9 months for drug-sensitive TB and up to 36 months for drug-resistant strains - MDR-TB and XDR-TB. Thus, new alternative approaches are urgently needed. One of them is immunotherapy, which is believed to enhance the efficacy of chemotherapy and shorten treatment duration.

The proprietary water-alcohol phytoconcentrate of 25 herbs, Immunoxel (Dzherelo), was developed by Ukrainian company Ekomed in 1997. This herbal tincture is widely available in Ukrainian pharmacies and has been used as an immune supplement to treat various infectious diseases such as seasonal flu, TB and HIV. Published studies spanning over the past 15 years count nearly tw
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vaccination reduces the risk of unvaccinated badger cubs testing tuberculosis positive
2. From the mouths of monkeys: Swab technique spots tuberculosis in non-human primates
3. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
4. Aeras and CNBG Sign Agreement on Tuberculosis Vaccine R&D
5. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
6. Cancer Immunotherapy Expert Joins Pacific Meso Center Research Team
7. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
8. OsteoVantage™ Receives Grant from the National Science Foundation
9. Boyd Coatings Awarded Workforce Training Grant
10. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
11. University of Minnesota awarded $28 million grant to lead microelectronics development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)...  Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading ... today announced that executives from the company will present ... , Pedro Lichtinger , Chief ... Annual Global Investment Conference on Wednesday, September 10, 2015 ... in New York City . ...
(Date:8/27/2015)... Boston, MA (PRWEB) , ... August 27, 2015 , ... ... the United States, ranking iLab Solutions as number 1,361 in growth for the three ... part of the top 0.1% fastest-growing privately held organizations in the country. , ...
(Date:8/26/2015)... KS (PRWEB) , ... August 26, 2015 , ... ... Biologic Solutions, announces today that a second US laboratory is to open in ... accordance with the continued partnership and long-term growth of research and development through ...
(Date:8/26/2015)... , Aug. 26, 2015  The Diabetes ... the University of Miami Miller School of Medicine, ... clinical trial to test for the first time ... successfully completed.  This FDA approved Phase I/II study ... transplantation and is an important first step toward ...
Breaking Biology Technology:Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4
... Sanofi-aventis announced,today that the anticoagulant Clexane(R) ... in Japan by the Ministry of Health, ... thromboembolism (VTE) in patients,undergoing orthopaedic surgery of ... total knee replacement and hip fracture surgery., ...
... MNKD ), focused on discovering, developing and,commercializing treatments for ... the Wachovia Healthcare Conference on January 30, 2008 at,2:00 ... Interested parties can access a link to the ... section of the Company,s website at, http://www.mannkindcorp.com . A ...
... Jan. 25 Cephalon, Inc., (Nasdaq:,CEPH) today announced ... has,accepted the company,s supplemental New Drug Application (sNDA) ... of,breakthrough pain in opioid-tolerant patients with chronic pain. ... will convene an advisory,committee panel on May 6, ...
Cached Biology Technology:Clexane(R)/Lovenox(R) Approved in Japan 2Clexane(R)/Lovenox(R) Approved in Japan 3Clexane(R)/Lovenox(R) Approved in Japan 4Clexane(R)/Lovenox(R) Approved in Japan 5Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 2Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 3
(Date:8/3/2015)... Aug. 3, 2015 Synaptics, Inc. (Nasdaq: ... today announced that members of the executive management team ... Crest Global Technology Leadership Forum on Tuesday, August 11, ... be held at the Sonnenalp Resort in ... may include forward-looking information. An audio webcast of the ...
(Date:7/31/2015)... julho de 2015 A 10 a. ... realizada pela BGI de 22-25 de outubro de 2015, em ... A conferência está celebrando seu 10 o. aniversário este ... tornou uma das reuniões mais influentes do mundo no ... dinâmicos, entusiastas e prazerosos. A ICG-10 ...
(Date:7/31/2015)... , 31. Juli 2015 Die 10. internationale Konferenz ... BGI veranstaltet und findet vom 22. bis 25. ... , statt. Die Konferenz feiert ... Start 2006 ist die ICG weltweit zu einem ... Sie ist eines der dynamischsten, enthusiastischsten und angenehmsten ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 2Die 10. internationale Konferenz zu Genomik (ICG-10) beginnt im Oktober 3
... Academy of Sciences will host the Fifth Annual ... design of oligosaccharides and proteins for materials and ... on the following areas: (1) synthetic and biosynthetic ... these macromolecules in materials science and glycobiology, (2) ...
... Kidney stones strike an estimated 1 million Americans each year, ... is among the worst known to man (or woman). ... Medicine in St. Louis provides evidence to explain why some ... Their discovery opens the door to finding effective drug treatments ...
... Concordia University is bringing us one step closer to clean ... a battery-like enzyme can store energy from seconds to hours, ... Chemical Society shows. Concordia Associate Professor Lszl Klmn ... graduate students Sasmit Deshmukh and Kai Tang has been ...
Cached Biology News:Kidney stone mystery solved 2Kidney stone mystery solved 3Nature's billion-year-old battery key to storing energy 2
2,4,6, Trinitrophenyl hapten is conjugated to lipopolysaccharide (LPS)....
For the quantitative determination of cyclic AMP (cAMP) concentrations in cell culture supernates, serum, plasma, saliva, urine and cell lysates....
... the Flp-In System creates isogenic cell ... levels of the protein of interest. ... Figure 3 (click link below). In ... chloramphenicol-acetyl transferase (CAT) was subcloned into ...
... solvents can be used, such as water, benzene, formamide, nitrobenzene, cyclohexane, 1,4-dioxane, p-xylene, dimethyl sulfoxide, freon ... * Range: 12-position switchable: ... ... ...
Biology Products: